返回 Agenda
Session 2: Health Canada Policy Priorities: Regulatory Review of Drugs/Devices, Cannabis, and the Controlled Drugs and Substance Strategy
Session Chair(s)
Marilena Bassi, MA
Senior Executive Director, Therapeutic Products Directorate, Health Canada, Canada
Senior officials from Health Canada will discuss current Departmental policy and regulatory priorities including initiatives to modernize regulatory review processes, the proposed legalization of cannabis and the federal government’s renewal of the controlled drugs and substance strategy.
Speaker(s)
Evelyn Soo, PHD, MS
Director, Bureau of Gastroenterology, Infection and Viral Diseases, HPFB, Health Canada, Canada
Overview of Health Canada’s Regulatory Review of Drugs and Devices
Chris Rose
Director, Cannabis Legalization and Regulation Branch, Health Canada, Canada
Proposed Cannabis Legalization
Kirsten Mattison
Director of Drug Policy and Science, Health Canada, Canada
Updating the Controlled Drugs and Substances Strategy
Panel Discussion
, All Session Speakers, United States